| # | Drug | Count |
|---|---|---|
| 0 | ESOMEPRAZOLE MAGNESIUM | 34 |
| 1 | RAMIPRIL | 34 |
| 2 | LEVOTHYROXINE SODIUM | 30 |
| 3 | EVEROLIMUS | 27 |
| 4 | LANSOPRAZOLE | 27 |
| 5 | ERGOCALCIFEROL | 26 |
| 6 | OMEPRAZOLE MAGNESIUM | 26 |
| 7 | OCTREOTIDE ACETATE | 25 |
| 8 | SUNITINIB MALATE | 25 |
| 9 | ROSUVASTATIN | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 1 | 0.0054 |
| 1 | SODIUM CITRATE | 5 | 0.0040 |
| 2 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 3 | CLEVIDIPINE | 1 | 0.0027 |
| 4 | MILTEFOSINE | 1 | 0.0026 |
| 5 | TETRACAINE | 1 | 0.0025 |
| 6 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 7 | ETHAMBUTOL HYDROCHLORIDE | 5 | 0.0018 |
| 8 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 9 | RITUXIMAB-ABBS | 8 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 46 |
| 1 | Corticosteroid [EPC] | 40 |
| 2 | Angiotensin Converting Enzyme Inhibitor [EPC] | 35 |
| 3 | Kinase Inhibitor [EPC] | 33 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 27 |
| 5 | mTOR Inhibitor Immunosuppressant [EPC] | 27 |
| 6 | Provitamin D2 Compound [EPC] | 26 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 25 |
| 8 | Loop Diuretic [EPC] | 23 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antileishmanial [EPC] | 1 | 0.0026 |
| 1 | Provitamin D2 Compound [EPC] | 26 | 0.0009 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 35 | 0.0003 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 6 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 7 | Antimalarial [EPC] | 2 | 0.0002 |
| 8 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 9 | Rifamycin Antibacterial [EPC] | 6 | 0.0002 |